Balancing Innovation and Sustainability: Employer Strategies for GLP-1 Coverage
Available On Demand
GLP-1 medications have quickly moved from niche diabetes treatments to a major driver of employer benefit strategy and specialty drug costs. In this panel discussion, experts from Aon, Blue Health Intelligence, and MedImpact explore how expanded GLP-1 coverage may impact employment-based health plans — and what it takes to balance innovation, access, and sustainability.
The speakers discuss real-world utilization trends, including demand growth, shifting indications, affordability barriers, and high discontinuation rates. They also highlight why wraparound support (clinical guidance, side-effect management, and lifestyle programs) can be critical to improving adherence and achieving meaningful health outcomes.
Key learning objectives:
- Understand key drivers influencing GLP-1 utilization and employer costs, including expanded indications, adherence challenges, and plan design decisions.
- Explore evidence-based strategies to improve outcomes through wraparound support (clinical guidance, side-effect management, nutrition, and lifestyle programs).
- Identify employer considerations for building a sustainable, multi-year approach to GLP-1 coverage that balances access, accountability, and financial impact.
Meet the Presenters
-
Heidi D. Burnett
Heidi D. Burnett is People Organization Leader and Global Human Sustainability at Aon.
-
Henriette Coetzer
Henriette Coetzer is Chief Medical Officer at Blue Health Intelligence.
-
Arpit Patel
Arpit Patel is Senior Vice President of Trade Relations at MedImpact.
-
Paul Fronstin
Paul Fronstin is Director, Health Benefits Research at Employee Benefit Research Institute (EBRI). (moderator)
SHRM certification has approved this webinar for 1 PDC toward SHRM-CP or SHRM-SCP recertification. A program code will be provided at the end of the webinar.